Bausch Health Companies Inc. Net Income (Loss) Attributable to Noncontrolling Interest
Bausch Health Companies Inc. (BHC) reported Net Income (Loss) Attributable to Noncontrolling Interest of $2.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAttributableToNoncontrollingInterest · last filed 2026-07-30
- Bausch Health Companies Inc. net income (loss) attributable to noncontrolling interest for the quarter ending 2026-06-30 was $2.00M.
- Bausch Health Companies Inc. net income (loss) attributable to noncontrolling interest for the quarter ending 2026-03-31 was -$8.00M.
- Bausch Health Companies Inc. net income (loss) attributable to noncontrolling interest for the quarter ending 2025-12-31 was $9.00M, a 80.00% increase year-over-year.
- Bausch Health Companies Inc. net income (loss) attributable to noncontrolling interest for the quarter ending 2025-09-30 was $2.00M.
- Bausch Health Companies Inc. net income (loss) attributable to noncontrolling interest for fiscal 2025 was -$37.00M.
- Bausch Health Companies Inc. net income (loss) attributable to noncontrolling interest for fiscal 2024 was -$26.00M.
- Bausch Health Companies Inc. net income (loss) attributable to noncontrolling interest for fiscal 2023 was -$19.00M, a 246.15% decline from fiscal 2022.
- Bausch Health Companies Inc. net income (loss) attributable to noncontrolling interest for fiscal 2022 was $13.00M, a 18.18% increase from fiscal 2021.
| Period end | Net Income (Loss) Attributable to Noncontrolling Interest 3 month | Net Income (Loss) Attributable to Noncontrolling Interest 3 month as first filed | Net Income (Loss) Attributable to Noncontrolling Interest 6 month | Net Income (Loss) Attributable to Noncontrolling Interest 6 month as first filed | Net Income (Loss) Attributable to Noncontrolling Interest 9 month | Net Income (Loss) Attributable to Noncontrolling Interest 9 month as first filed | Net Income (Loss) Attributable to Noncontrolling Interest 12 month | Net Income (Loss) Attributable to Noncontrolling Interest 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $2.00M 10-Q · filed 2026-07-30 | -$6.00M 10-Q · filed 2026-07-30 | $3.00M derived: sum of 3 quarters · filed 2026-07-30 | $5.00M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2026-03-31 | -$8.00M 10-Q · filed 2026-04-30 | $1.00M derived: sum of 2 quarters · filed 2026-04-30 | $3.00M derived: sum of 3 quarters · filed 2026-04-30 | -$17.00M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-12-31 | $9.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $11.00M derived: sum of 2 quarters · filed 2026-02-19 | -$9.00M derived: sum of 3 quarters · filed 2026-07-30 | -$37.00M 10-K · filed 2026-02-19 | ||||
| 2025-09-30 | $2.00M 10-Q · filed 2025-10-30 | -$18.00M derived: sum of 2 quarters · filed 2026-07-30 | -$46.00M 10-Q · filed 2025-10-30 | -$41.00M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-06-30 | -$20.00M 10-Q · filed 2026-07-30 | -$48.00M 10-Q · filed 2026-07-30 | -$43.00M derived: sum of 3 quarters · filed 2026-07-30 | -$50.00M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-03-31 | -$28.00M 10-Q · filed 2026-04-30 | -$23.00M derived: sum of 2 quarters · filed 2026-04-30 | -$30.00M derived: sum of 3 quarters · filed 2026-04-30 | -$41.00M derived: sum of 4 quarters · filed 2026-04-30 | ||||
| 2024-12-31 | $5.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$2.00M derived: sum of 2 quarters · filed 2026-02-19 | -$13.00M derived: sum of 3 quarters · filed 2026-02-19 | -$26.00M 10-K · filed 2026-02-19 | ||||
| 2024-09-30 | -$7.00M 10-Q · filed 2025-10-30 | -$18.00M derived: sum of 2 quarters · filed 2025-10-30 | -$31.00M 10-Q · filed 2025-10-30 | -$39.00M derived: sum of 4 quarters · filed 2026-02-19 | ||||
| 2024-06-30 | -$11.00M 10-Q · filed 2025-07-31 | -$24.00M 10-Q · filed 2025-07-31 | -$32.00M derived: sum of 3 quarters · filed 2026-02-19 | -$36.00M derived: sum of 4 quarters · filed 2026-02-19 | ||||
| 2024-03-31 | -$13.00M 10-Q · filed 2025-05-01 | -$21.00M derived: sum of 2 quarters · filed 2026-02-19 | -$25.00M derived: sum of 3 quarters · filed 2026-02-19 | -$24.00M derived: sum of 4 quarters · filed 2026-02-19 | ||||
| 2023-12-31 | -$8.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$12.00M derived: sum of 2 quarters · filed 2026-02-19 | -$11.00M derived: sum of 3 quarters · filed 2026-02-19 | -$19.00M 10-K · filed 2026-02-19 | ||||
| 2023-09-30 | -$4.00M 10-Q · filed 2024-10-31 | -$3.00M derived: sum of 2 quarters · filed 2024-10-31 | -$11.00M 10-Q · filed 2024-10-31 | -$11.00M derived: sum of 4 quarters · filed 2025-02-20 | ||||
| 2023-06-30 | $1.00M 10-Q · filed 2024-08-01 | -$7.00M 10-Q · filed 2024-08-01 | -$7.00M derived: sum of 3 quarters · filed 2025-02-20 | -$3.00M derived: sum of 4 quarters · filed 2025-02-20 | ||||
| 2023-03-31 | -$8.00M 10-Q · filed 2024-05-02 | -$8.00M derived: sum of 2 quarters · filed 2025-02-20 | -$4.00M derived: sum of 3 quarters · filed 2025-02-20 | $2.00M derived: sum of 4 quarters · filed 2025-02-20 | ||||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $4.00M derived: sum of 2 quarters · filed 2025-02-20 | $10.00M derived: sum of 3 quarters · filed 2025-02-20 | $13.00M 10-K · filed 2025-02-20 | ||||
| 2022-09-30 | $4.00M 10-Q · filed 2023-11-02 | $10.00M derived: sum of 2 quarters · filed 2023-11-02 | $13.00M 10-Q · filed 2023-11-02 | $16.00M derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2022-06-30 | $6.00M 10-Q · filed 2023-08-03 | $9.00M 10-Q · filed 2023-08-03 | $12.00M derived: sum of 3 quarters · filed 2024-02-22 | $15.00M derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2022-03-31 | $3.00M 10-Q · filed 2023-05-04 | $6.00M derived: sum of 2 quarters · filed 2024-02-22 | $9.00M derived: sum of 3 quarters · filed 2024-02-22 | $11.00M derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2021-12-31 | $3.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $6.00M derived: sum of 2 quarters · filed 2024-02-22 | $8.00M derived: sum of 3 quarters · filed 2024-02-22 | $11.00M 10-K · filed 2024-02-22 | ||||
| 2021-09-30 | $3.00M 10-Q · filed 2022-11-03 | $5.00M derived: sum of 2 quarters · filed 2022-11-03 | $8.00M 10-Q · filed 2022-11-03 | $9.00M derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2021-06-30 | $2.00M 10-Q · filed 2022-08-09 | $5.00M 10-Q · filed 2022-08-09 | $6.00M derived: sum of 3 quarters · filed 2023-02-23 | $5.00M derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2021-03-31 | $3.00M 10-Q · filed 2022-05-10 | $4.00M derived: sum of 2 quarters · filed 2023-02-23 | $3.00M derived: sum of 3 quarters · filed 2023-02-23 | $4.00M derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2020-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $0.00 derived: sum of 2 quarters · filed 2023-02-23 | $1.00M derived: sum of 3 quarters · filed 2023-02-23 | $1.00M 10-K · filed 2023-02-23 | ||||
| 2020-09-30 | -$1.00M 10-Q · filed 2021-11-02 | $0.00 derived: sum of 2 quarters · filed 2021-11-02 | $0.00 10-Q · filed 2021-11-02 | -$1.00M derived: sum of 4 quarters · filed 2022-05-11 | ||||
| 2020-06-30 | $1.00M 10-Q · filed 2021-08-03 | $1.00M 10-Q · filed 2021-08-03 | $0.00 derived: sum of 3 quarters · filed 2022-05-11 | $1.00M derived: sum of 4 quarters · filed 2022-05-11 | ||||
| 2020-03-31 | $0.00 10-Q · filed 2021-05-04 | -$1.00M derived: sum of 2 quarters · filed 2022-05-11 | $0.00 derived: sum of 3 quarters · filed 2022-05-11 | $1.00M derived: sum of 4 quarters · filed 2022-05-11 | ||||
| 2019-12-31 | -$1.00M derived: 8-K 12 month − 10-Q 9 month · filed 2022-05-11 | $0.00 derived: sum of 2 quarters · filed 2022-05-11 | $1.00M derived: sum of 3 quarters · filed 2022-05-11 | $5.00M 8-K · filed 2022-05-11 | ||||
| 2019-09-30 | $1.00M 10-Q · filed 2020-11-03 | $2.00M derived: sum of 2 quarters · filed 2020-11-03 | $6.00M 10-Q · filed 2020-11-03 | $8.00M derived: sum of 4 quarters · filed 2021-05-04 | ||||
| 2019-06-30 | $1.00M 10-Q · filed 2020-08-06 | $5.00M 10-Q · filed 2020-08-06 | $7.00M derived: sum of 3 quarters · filed 2021-05-04 | $6.00M derived: sum of 4 quarters · filed 2021-05-04 | ||||
| 2019-03-31 | $4.00M 10-Q · filed 2020-05-07 | $6.00M derived: sum of 2 quarters · filed 2021-05-04 | $5.00M derived: sum of 3 quarters · filed 2021-05-04 | $6.00M derived: sum of 4 quarters · filed 2021-05-04 | ||||
| 2018-12-31 | $2.00M derived: 8-K 12 month − 10-Q 9 month · filed 2021-05-04 | $1.00M derived: sum of 2 quarters · filed 2021-05-04 | $2.00M derived: sum of 3 quarters · filed 2021-05-04 | $4.00M 8-K · filed 2021-05-04 | ||||
| 2018-09-30 | -$1.00M 10-Q · filed 2019-11-04 | $0.00 derived: sum of 2 quarters · filed 2019-11-04 | $2.00M 10-Q · filed 2019-11-04 | $1.00M derived: sum of 4 quarters · filed 2020-02-19 | ||||
| 2018-06-30 | $1.00M 10-Q · filed 2019-08-06 | $3.00M 10-Q · filed 2019-08-06 | $2.00M derived: sum of 3 quarters · filed 2020-02-19 | $1.00M derived: sum of 4 quarters · filed 2020-02-19 | ||||
| 2018-03-31 | $2.00M 10-Q · filed 2019-05-06 | $1.00M derived: sum of 2 quarters · filed 2020-02-19 | $0.00 derived: sum of 3 quarters · filed 2020-02-19 | $1.00M derived: sum of 4 quarters · filed 2020-02-19 | ||||
| 2017-12-31 | -$1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19 | -$2.00M derived: sum of 2 quarters · filed 2020-02-19 | -$1.00M derived: sum of 3 quarters · filed 2020-02-19 | $0.00 10-K · filed 2020-02-19 | ||||
| 2017-09-30 | -$1.00M 10-Q · filed 2018-11-06 | $0.00 derived: sum of 2 quarters · filed 2018-11-06 | $1.00M 10-Q · filed 2018-11-06 | $4.00M derived: sum of 4 quarters · filed 2019-02-20 | ||||
| 2017-06-30 | $1.00M 10-Q · filed 2018-08-07 | $2.00M 10-Q · filed 2018-08-07 | $5.00M derived: sum of 3 quarters · filed 2019-02-20 | $4.00M derived: sum of 4 quarters · filed 2019-02-20 | ||||
| 2017-03-31 | $1.00M 10-Q · filed 2018-05-08 | $4.00M derived: sum of 2 quarters · filed 2019-02-20 | $3.00M derived: sum of 3 quarters · filed 2019-02-20 | $1.00M derived: sum of 4 quarters · filed 2019-02-20 | ||||
| 2016-12-31 | $3.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-20 | $2.00M derived: sum of 2 quarters · filed 2019-02-20 | $0.00 derived: sum of 3 quarters · filed 2019-02-20 | $1.00M 10-K · filed 2019-02-20 | ||||
| 2016-09-30 | -$1.00M 10-Q · filed 2017-11-07 | -$700.00K 10-Q · filed 2016-11-09 | -$3.00M derived: sum of 2 quarters · filed 2017-11-07 | -$2.00M 10-Q · filed 2017-11-07 | -$1.60M 10-Q · filed 2016-11-09 | -$2.40M derived: sum of 4 quarters · filed 2018-08-10 | ||
| 2016-06-30 | -$2.00M 10-Q · filed 2017-08-08 | -$1.70M 10-Q · filed 2016-08-09 | -$1.00M 10-Q · filed 2017-08-08 | -$900.00K 10-Q · filed 2016-08-09 | -$1.40M derived: sum of 3 quarters · filed 2018-08-10 | $800.00K derived: sum of 4 quarters · filed 2018-08-10 | ||
| 2016-03-31 | $1.00M 10-Q · filed 2017-05-09 | $800.00K 10-Q · filed 2016-06-07 | $600.00K derived: sum of 2 quarters · filed 2018-08-10 | $2.80M derived: sum of 3 quarters · filed 2018-08-10 | $4.20M derived: sum of 4 quarters · filed 2018-08-10 | |||
| 2015-12-31 | -$400.00K derived: 8-K 12 month − 10-Q 9 month · filed 2018-08-10 | $1.80M derived: sum of 2 quarters · filed 2018-08-10 | $3.20M derived: sum of 3 quarters · filed 2018-08-10 | $4.00M 8-K · filed 2018-08-10 | $3.90M 10-K · filed 2016-04-29 | |||
| 2015-09-30 | $2.20M 10-Q · filed 2016-11-09 | $3.60M derived: sum of 2 quarters · filed 2016-11-09 | $4.40M 10-Q · filed 2016-11-09 | $3.90M derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2015-06-30 | $1.40M 10-Q · filed 2016-08-09 | $2.20M 10-Q · filed 2016-08-09 | $1.70M derived: sum of 3 quarters · filed 2017-03-01 | $2.70M derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2015-03-31 | $800.00K 10-Q · filed 2016-06-07 | $300.00K derived: sum of 2 quarters · filed 2017-03-01 | $1.30M derived: sum of 3 quarters · filed 2017-03-01 | -$2.50M derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2014-12-31 | -$500.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $500.00K derived: sum of 2 quarters · filed 2017-03-01 | -$3.30M derived: sum of 3 quarters · filed 2017-03-01 | -$1.00M 10-K · filed 2017-03-01 | -$1.30M 10-K · filed 2015-02-25 | |||
| 2014-09-30 | $1.00M 10-Q · filed 2015-10-26 | -$2.80M derived: sum of 2 quarters · filed 2015-10-26 | -$500.00K 10-Q · filed 2015-10-26 | $700.00K derived: sum of 4 quarters · filed 2016-04-29 | ||||
| 2014-06-30 | -$3.80M 10-Q · filed 2015-07-28 | -$1.50M 10-Q · filed 2015-07-28 | -$300.00K derived: sum of 3 quarters · filed 2016-04-29 | $1.00M derived: sum of 4 quarters · filed 2016-04-29 | ||||
| 2014-03-31 | $2.30M 10-Q · filed 2015-04-30 | $3.50M derived: sum of 2 quarters · filed 2016-04-29 | $4.80M derived: sum of 3 quarters · filed 2016-04-29 | $4.80M derived: sum of 4 quarters · filed 2016-04-29 | ||||
| 2013-12-31 | $1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2016-04-29 | $2.50M derived: sum of 2 quarters · filed 2016-04-29 | $2.50M derived: sum of 3 quarters · filed 2016-04-29 | $2.50M 10-K · filed 2016-04-29 | $2.47M 10-K · filed 2014-02-28 | |||
| 2013-09-30 | $1.30M 10-Q · filed 2014-10-24 | $1.27M 10-Q · filed 2013-11-01 | $1.30M derived: sum of 2 quarters · filed 2014-10-24 | $1.30M 10-Q · filed 2014-10-24 | $1.27M 10-Q · filed 2013-11-01 | $1.30M derived: sum of 4 quarters · filed 2015-02-25 | ||
| 2013-06-30 | $0.00 10-Q · filed 2014-08-01 | $0.00 10-Q · filed 2014-08-01 | $0.00 derived: sum of 3 quarters · filed 2015-02-25 | $0.00 derived: sum of 4 quarters · filed 2015-02-25 | ||||
| 2013-03-31 | $0.00 10-Q · filed 2014-05-09 | $0.00 derived: sum of 2 quarters · filed 2015-02-25 | $0.00 derived: sum of 3 quarters · filed 2015-02-25 | |||||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25 | $0.00 derived: sum of 2 quarters · filed 2015-02-25 | $0.00 10-K · filed 2015-02-25 | |||||
| 2012-09-30 | $0.00 10-Q · filed 2013-11-01 | $0.00 10-Q · filed 2013-11-01 | ||||||
| 2011-12-31 | $0.00 10-K · filed 2014-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 |